All Stories

  1. Epsilon waves as an extreme form of depolarization delay: focus on the arrhythmogenic right ventricular cardiomyopathy/dysplasia
  2. OUP accepted manuscript
  3. Rate‐Control Drugs Affect Variability and Irregularity Measures of RR Intervals in Patients with Permanent Atrial Fibrillation
  4. Atrial fibrillatory rate in the clinical context: natural course and prediction of intervention outcome
  5. Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members
  6. Predictors of Successful Cardioversion with Vernakalant in Patients with Recent‐Onset Atrial Fibrillation
  7. Transient and rapid QRS-widening associated with a J-wave pattern predicts impending ventricular fibrillation in experimental myocardial infarction
  8. Pre-hospital evaluation of electrocardiographic grade 3 ischemia predicts infarct progression and final infarct size in ST elevation myocardial infarction patients treated with primary percutaneous coronary intervention
  9. P-wave characteristics and histological atrial abnormality
  10. HRV regularity during persistent atrial fibrillation: A parametric assessment using sample entropy
  11. GENETIC VARIANTS IN SOX5 AND CAV1 ARE ASSOCIATED WITH ABNORMAL ATRIAL ACTIVATION IN PATIENTS WITH LONE ATRIAL FIBRILLATION
  12. PERIPHERAL MICROVASCULAR FUNCTION IS ALTERED IN YOUNG INDIVIDUALS AT RISK FOR HYPERTROPHIC CARDIOMYOPATHY AND CORRELATES WITH DIASTOLIC MYOCARDIAL FUNCTION
  13. CLINICAL RISK PROFILE DOES NOT PREDICT IMPLANTABLE DEFIBRILLATOR (ICD) INTERVENTION RATE IN AN UNSELECTED COHORT OF PATIENTS WITH CONGESTIVE HEART FAILURE
  14. P-WAVE MORPHOLOGY IS UNAFFECTED BY ATRIAL SIZE: A STUDY IN HEALTHY ATHLETES
  15. MALE GENDER AND STRUCTURAL RIGHT VENTRICULAR ABNORMALITY BY IMAGING INDEPENDENTLY PREDICT SYMPTOMS IN PATIENTS WITH ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY
  16. P-Wave Morphology Is Unaffected by Atrial Size: A Study in Healthy Athletes
  17. P‐wave Morphology Is Associated with Echocardiographic Response to Cardiac Resynchronization Therapy in MADIT‐CRT Patients
  18. In-silico modeling of atrial repolarization in normal and atrial fibrillation remodeled state
  19. T wave alternans in experimental myocardial infarction: Time course and predictive value for the assessment of myocardial damage
  20. Prognostic implications of mutation-specific QTc standard deviation in congenital long QT syndrome
  21. Genetic polymorphisms confer risk of atrial fibrillation in patients with heart failure: a population‐based study
  22. HEART TRANSPLANTATIONS IN THE NORDIC ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY REGISTRY
  23. Comparison of Four Single-Drug Regimens on Ventricular Rate and Arrhythmia-Related Symptoms in Patients With Permanent Atrial Fibrillation
  24. Association between Atrial Fibrillatory Rate and Heart Rate Variability in Patients with Atrial Fibrillation and Congestive Heart Failure
  25. Characterization of ventricular depolarization and repolarization changes in a porcine model of myocardial infarction
  26. Analysis of atrial fibrillatory rate during spontaneous episodes of atrial fibrillation in humans using implantable loop recorder electrocardiogram
  27. In Silico Cardiac Risk Assessment in Patients With Long QT Syndrome
  28. Aortic stenosis and mitral regurgitation as predictors of atrial fibrillation during 11 years of follow-up
  29. Interatrial blocks. A separate entity from left atrial enlargement: a consensus report
  30. P‐Wave Morphology: Underlying Mechanisms and Clinical Implications
  31. Combined assessment of sex- and mutation-specific information for risk stratification in type 1 long QT syndrome
  32. Atrial fibrillatory rate and irregularity of ventricular response as predictors of clinical outcome in patients with atrial fibrillation
  33. Structural Abnormalities in Atrial Walls Are Associated With Presence and Persistency of Atrial Fibrillation But Not With Age
  34. Mutation and gender-specific risk in type 2 long QT syndrome: Implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome
  35. Evaluation of depolarization changes during acute myocardial ischemia by analysis of QRS slopes
  36. International Congress on Electrocardiology 2010 in Lund, Sweden
  37. Analysis of QRS slopes as a measure of depolarization changes during acute myocardial ischemia
  38. Noninvasive estimation of organization in atrial fibrillation as a predictor of sinus rhythm maintenance
  39. Abnormal atrial activation is common in patients with arrhythmogenic right ventricular cardiomyopathy
  40. Conduction patterns in the coronary sinus during atrial fibrillation and their modification by pulmonary vein isolation
  41. Noninvasive estimation of organization in atrial fibrillation as a predictor of sinus rhythm maintenance
  42. The relationship between ST-dynamics during reperfusion and the infarct size in experimental myocardial infarction
  43. Effects of atrial septal pacing sites on the P-wave duration correlated with baseline P-wave duration and morphology
  44. Preferential conduction patterns along the coronary sinus during atrial fibrillation in humans and their modification by pulmonary vein isolation
  45. ST-segment dynamics during reperfusion period and the size of myocardial injury in experimental myocardial infarction
  46. Risk for Life-Threatening Cardiac Events in Patients With Genotype-Confirmed Long-QT Syndrome and Normal-Range Corrected QT Intervals
  47. Detection of hypertrophic cardiomyopathy is improved when using advanced rather than strictly conventional 12-lead electrocardiogram
  48. Assessment of Conventional Cardiovascular Risk Factors and Multiple Biomarkers for the Prediction of Incident Heart Failure and Atrial Fibrillation
  49. Left Atrial Appendage Activity Translation in the Standard 12-Lead ECG
  50. Comparison of high-frequency QRS components and ST-segment elevation to detect and quantify acute myocardial ischemia
  51. Abnormal P‐Wave Morphology Is a Predictor of Atrial Fibrillation Development and Cardiac Death in MADIT II Patients
  52. Atrial fibrillation in the Malmö diet and cancer study: a study of occurrence, risk factors and diagnostic validity
  53. Clinical Predictors of Termination and Clinical Outcome of Catheter Ablation for Persistent Atrial Fibrillation
  54. Evolution of P‐Wave Morphology in Healthy Individuals: A 3‐Year Follow‐Up Study
  55. Altered Interatrial Conduction Detected in MADIT II Patients Bound to Develop Atrial Fibrillation
  56. Clinical value of fibrillatory wave amplitude on surface ECG in patients with persistent atrial fibrillation
  57. Substrate for development of atrial fibrillation in patients with congestive heart failure: Are we close to the answer?
  58. Interatrial right-to-left conduction in patients with paroxysmal atrial fibrillation
  59. Noninvasive Evidence of Shortened Atrial Refractoriness during Sinus Rhythm in Patients with Paroxysmal Atrial Fibrillation
  60. Detailed ECG Analysis of Atrial Repolarization in Humans
  61. Substrates for intra-atrial and interatrial conduction in the atrial septum: Anatomical study on 84 human hearts
  62. Left Atrial Posterior Wall Thickness in Patients with and without Atrial Fibrillation: Data from 298 Consecutive Autopsies
  63. Interatrial conduction can be accurately determined using standard 12-lead electrocardiography: Validation of P-wave morphology using electroanatomic mapping in man
  64. Signal-averaged P wave analysis for delineation of interatrial conduction – Further validation of the method
  65. Duration of P‐Wave Is Associated with Atrial Fibrillation Hospitalizations in Patients with Atrial Fibrillation and Paced for Bradycardia
  66. Age-related changes in P wave morphology in healthy subjects
  67. Variable Interatrial Conduction Illustrated in a Hypertrophic Cardiomyopathy Population
  68. Interatrial impulse propagation in patients with paroxysmal atrial fibrillation
  69. Non-fluoroscopic catheter-based mapping systems in cardiac electrophysiology—from approved clinical indications to novel research usage
  70. Clinical Trials in Russia
  71. Geographic variability in patient characteristics, treatment and outcome in an international trial of magnesium in acute myocardial infarction
  72. Deterioration of interatrial conduction in patients with paroxysmal atrial fibrillation: Electroanatomic mapping of the right atrium and coronary sinus
  73. Analysis of the Surface Electrocardiogram for Monitoring and Predicting Antiarrhythmic Drug Effects in Atrial Fibrillation
  74. Left Atrial Conduction Along the Coronary Sinus During Ectopic Atrial Tachycardia and Atrial Fibrillation: